MAMO.CZ http://www.mamo.cz Research project guaranteed by the Expert Committee on Breast Radiology (KOMD) and the Czech Ministry of Health. Collection and analysis of data from the Czech Breast Cancer Screening Programme. Organizational and educational materials on breast cancer prevention. en Mon, 20 May 2013 17:28:18 GMT Mon, 20 May 2013 17:28:18 GMT MAMO.CZ http://www.mamo.cz/images/logo-rss.png http://www.mamo.cz Research project guaranteed by the Expert Committee on Breast Radiology (KOMD) and the Czech Ministry of Health. Collection and analysis of data from the Czech Breast Cancer Screening Programme. Organizational and educational materials on breast cancer prevention. 60 60 Mammograms reveal response to common cancer drug http://www.mamo.cz/index.php?pg=aktuality&aid=552 Researchers at Karolinska Institutet have developed a method for assessing the effect of tamoxifen, a common drug to prevent the relapse of breast cancer. The key lies in monitoring changes in the proportion of dense tissue, which appears white on a mammogram, during treatment. Women who show a pronounced reduction in breast density during tamoxifen treatment have a fifty per cent reduction in breast cancer mortality. This tool provides doctors with the possibility to assess whether a patient is responding to tamoxifen at an early phase of treatment. Tue, 23 Apr 2013 08:00:00 GMT http://www.mamo.cz/index.php?pg=aktuality&aid=552 Scientists find promising new target for aggressive breast cancer http://www.mamo.cz/index.php?pg=aktuality&aid=549 Women with triple-negative breast cancer are more likely to have high levels of the MET biomarker in their tumours, making it a good new target for cancer drugs according to research published in the British Journal of Cancer, today (Wednesday). Wed, 20 Mar 2013 09:00:00 GMT http://www.mamo.cz/index.php?pg=aktuality&aid=549 Study examines outcomes of screening mammography for age, breast density, hormone therapy http://www.mamo.cz/index.php?pg=aktuality&aid=544 A study that compared the benefits and harms of the frequency of screening mammography to age, breast density and postmenopausal use of hormone therapy (HT) suggests that woman aged 50 to 74 years who undergo biennial screenings have a similar risk of advanced-stage disease and a lower cumulative risk of false-positive results than those who get mammograms annually, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication. Mon, 18 Mar 2013 09:00:00 GMT http://www.mamo.cz/index.php?pg=aktuality&aid=544 Heart disease risk after breast cancer radiotherapy smaller than previously thought http://www.mamo.cz/index.php?pg=aktuality&aid=539 Researchers have for the first time calculated by how much radiotherapy for breast cancer increases the risk of heart disease and the findings can now be used by doctors to help treat patients more appropriately, according to a study published in the New England Journal of Medicine today (Wednesday). Wed, 13 Mar 2013 09:00:00 GMT http://www.mamo.cz/index.php?pg=aktuality&aid=539 Blood test reveals women's response to breast cancer treatment http://www.mamo.cz/index.php?pg=aktuality&aid=541 Breast tumour DNA circulating in the bloodstream could be used to measure how well a woman’s cancer is responding to treatment, according to a new Cancer Research UK study published in the New England Journal of Medicine. Wed, 13 Mar 2013 09:00:00 GMT http://www.mamo.cz/index.php?pg=aktuality&aid=541 Study links cigarette smoking, breast cancer risk http://www.mamo.cz/index.php?pg=aktuality&aid=537 Results from a new American Cancer Society study support the hypothesis that smoking is associated with increased breast cancer risk for women who initiate smoking before first birth. The study, which appears online in the Journal of the National Cancer Institute, suggests that smoking might play a role in initiating breast cancer. Thu, 28 Feb 2013 09:00:00 GMT http://www.mamo.cz/index.php?pg=aktuality&aid=537 Lab research suggests more women could benefit from Herceptin http://www.mamo.cz/index.php?pg=aktuality&aid=534 Herceptin may be effective against more types of breast cancer than previously thought, according to US research. Tue, 26 Feb 2013 09:00:00 GMT http://www.mamo.cz/index.php?pg=aktuality&aid=534 APOBEC3B is an enzymatic source of mutation in breast cancer http://www.mamo.cz/index.php?pg=aktuality&aid=532 Genetic errors driving the majority of breast cancers may be caused by a hyperactive enzyme called APOBEC3B, according to US researchers. Fri, 08 Feb 2013 09:00:00 GMT http://www.mamo.cz/index.php?pg=aktuality&aid=532 Inherited gene fault influences breast cancer survival http://www.mamo.cz/index.php?pg=aktuality&aid=522 Researchers have shown that an inherited gene fault influences the chances of some women surviving breast cancer. It also increases the risk of women developing a second breast cancer. The research is published in this week’s Journal of Clinical Oncology. Sat, 11 Feb 2012 09:00:00 GMT http://www.mamo.cz/index.php?pg=aktuality&aid=522 Updated information on breast cancer epidemiology http://www.mamo.cz/index.php?pg=aktuality&aid=523 Information on breast cancer epidemiology in the Czech Republic has been updated in the section "For health professionals". Sat, 11 Feb 2012 09:00:00 GMT http://www.mamo.cz/index.php?pg=aktuality&aid=523